| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/07/2008 | WO2008094249A1 Model predictive method and system for controlling and supervising insulin infusion |
| 08/07/2008 | WO2008093838A1 Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | US20080188557 Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof |
| 08/07/2008 | US20080188548 Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof |
| 08/07/2008 | US20080188519 Novel azacyclic ethynyl derivatives |
| 08/07/2008 | US20080188447 Glucocorticoid-lowering composition |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | CA2672589A1 Model predictive method and system for controlling and supervising insulin infusion |
| 08/06/2008 | EP1953165A1 Aza-substituted spiro derivative |
| 08/06/2008 | EP1953162A1 Xanthin derivatives, their production and utilisation as medicine |
| 08/06/2008 | EP1952814A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 08/06/2008 | EP1952809A2 Formulations for the reduction of breast density with 4-Hydroxy Tamoxifen |
| 08/06/2008 | EP1952701A2 Improving longevity and the condition of elderly cats |
| 08/06/2008 | EP1951727A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 08/06/2008 | EP1951286A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 08/06/2008 | EP1951250A2 Chemical compounds |
| 08/06/2008 | EP1951242A2 Combination therapy for the treatment of cancer |
| 08/06/2008 | EP1951217A2 Chemical compounds |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1147133B1 Peptides consisting of two PTH functional domains fused by a linker molecule, and derivatives thereof |
| 08/06/2008 | CN101237889A Estrogen compositions for vaginal administration |
| 08/06/2008 | CN101237851A Estrogen compositions for vaginal administration |
| 08/06/2008 | CN100408579C Xanthine derivative, production and use thereof as a medicament |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408098C Application polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of tumor and diabetes mellitus |
| 08/05/2008 | US7408046 Administering anticarcinogenic agent and chelate complex of macrocyclic aminophosphonic acid and radionuclide such as samarium ethylenediaminetetramethylenephosphonic acid (EDTMP) to replace total body irradiation;antiproliferative agents; autoimmune, infectious, metabolic or genetic disorders |
| 08/05/2008 | US7408024 Somatostatin antagonists |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407932 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 08/05/2008 | US7407649 Silicon compounds and their use |
| 08/05/2008 | CA2473718C Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
| 08/05/2008 | CA2290622C Selective thyroid hormone analogs |
| 08/05/2008 | CA2279319C Benzofurazan compounds which enhance ampa receptor activity |
| 08/05/2008 | CA2207136C New 1 or 6-hydroxyl steroids, their preparation process, their application as drugs and the pharmaceutical compositions surrounding them |
| 07/31/2008 | WO2008091177A1 Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
| 07/31/2008 | WO2008091167A1 Topical formulation |
| 07/31/2008 | WO2008090356A1 Thiazolidinone derivatives useful in the treatment of cancer and disorders caused by excess adiposity |
| 07/31/2008 | WO2008089521A1 Insulin sensitisers and methods of treatment |
| 07/31/2008 | WO2008031061A3 Anti-activin a antibodies and uses thereof |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182828 dominant estrogenic activity phase of three daily doses of an estrogen equivalent to 1 mg per day of 17 beta -estradiol per day and a dominant progestagenic activity phase of a combination of an estrogen and a progestogen equivalent to 90 mu g per day of norgestimate; hot flushes |
| 07/31/2008 | US20080182775 Administering analogs of luteinizing hormone-releasing hormone, leuprolide; inhibits testosterone secretion |
| 07/31/2008 | US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 07/31/2008 | CA2713199A1 Topical formulation |
| 07/31/2008 | CA2676051A1 Insulin sensitisers and methods of treatment |
| 07/30/2008 | EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949908A1 Combined use of derivatives of GLP-1 analogs and PPAR ligands |
| 07/30/2008 | EP1949890A2 Implantable gel compositions and method of manufacture |
| 07/30/2008 | EP1948665A2 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 07/30/2008 | EP1948238A1 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | CN101232873A Pharmaceutical composition comprising a dpp-iv inhibitor |
| 07/30/2008 | CN101229165A Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 07/30/2008 | CN100406570C Sgk and Nedd used as diagnostic and therapeutic targets |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406063C External-applied ointment used for treating thyropathy, and its preparing method |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 07/29/2008 | US7404974 A ground plant extract of Mascagnia eggersiana, a subspecies, or ecotype; improved peripheral blood flow; few side effects |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2201377C Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/24/2008 | WO2008088935A2 Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008073956A3 Cyclic sulfonamide derivatives and methods of their use |
| 07/24/2008 | US20080177042 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177041 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 07/24/2008 | US20080177037 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
| 07/24/2008 | US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones |
| 07/24/2008 | US20080175905 Estrogen/serm and estrogen/progestin bi-layer tablets |
| 07/24/2008 | US20080175865 inoculation with a mixture of deactivated forms lactobacillus strains |
| 07/24/2008 | US20080175828 Proliferated cell lines and uses thereof |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/24/2008 | CA2674440A1 Methods for improved stability of steroid derivatives |
| 07/23/2008 | EP1945238A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 07/23/2008 | EP1945212A1 Treatment of diabetes |
| 07/23/2008 | EP1239829B1 Devices for the delivery of drugs having antiprogestinic properties |
| 07/23/2008 | EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 07/23/2008 | CN101228177A 3-ester prodrugs of estradiol |
| 07/23/2008 | CN101228135A Pyridazinone derivatives as thyroid hormone receptor agonists |
| 07/23/2008 | CN101227892A Buccal delivery system |
| 07/23/2008 | CN101224238A External methyl tes tosterone preparation |
| 07/23/2008 | CN100404535C Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 07/23/2008 | CN100404508C Tetrahydroquinoline derivatives |
| 07/23/2008 | CN100404068C Injection solution comprising an LHRH antagonist |
| 07/23/2008 | CN100404059C Chinese medicine for treating hyperthyroidism and its preparation |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/22/2008 | US7402611 Use of amino acids for making medicines for treating to insulin-resistance |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |